Hani Enaya
Angel Investor @ STV
Riyadh, Saudi Arabia
Hani Enaya is a Series A investor at STV in Riyadh focused on Medical and Software. Hani Enaya is the head of venture capital at Sanabil Investments.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Hani Enaya invests in
Stages Hani Enaya invests in
Countries Hani Enaya invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 2 (67%)
- Software 2 (67%)
- Health Care 2 (67%)
- Apps 1 (33%)
- Biotechnology 1 (33%)
Stage
- Series A 1 (33%)
- Series B 1 (33%)
- Series C 1 (33%)
Country
- Saudi Arabia 1 (33%)
- United States 1 (33%)
- United Arab Emirates 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any otherAI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster. Learn more at atomwise.com, or connect on Twitter and LinkedIn. | $123M / Series B / Aug 11, 2020 | ||
| MRSOOL connects with people around you who will help you with your tasks! Concierge service affordable to the masses delivered by the crowd. | Series A / Mar 12, 2019 | ||
| Vezeeta is the digital healthcare platform in MEA that connects patients with healthcare providers and health services. Patients are able to search, compare, book, and review the best doctors in Egypt, Saudi Arabia, Jordan, and Lebanon. It also provides innovative SaaS solutions to healthcare providers in the region. Vezeeta empowers millions ofpatients through data and the ability to better access healthcare in the region. With over 200,000 verified reviews, patients are able to search, compare, and book the best doctors in just 1 minute. Doctors also provide Patients with seamless healthcare experiences through our clinic management software. | $12M / Series C / Sep 19, 2018 |
Co-Investors
About STV
STV is an independent VC fund that is anchored by STC (MENA's largest telecom operator) with access to its assets (e.g., network, channels, analytics, customer base, etc) to enable its portfolio companies to scale. (Operation started in early 2018)
STV Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Abdulrahman Tarabzouni
Founder, CEO & MD
|
|||
Ahmad AlNaimi
Partner
|
|||
|
Ahmad Alshammari
Partner
|
|||
Ihsan Jawad
General Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Hani Enaya invest in?
Hani Enaya invests primarily in Medical, Software and Health Care startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in Saudi Arabia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Hani Enaya?
Public channels for Hani Enaya include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Hani Enaya last invest?
The most recent investment recorded for Hani Enaya closed in Aug 2020. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
